Cargando…
Characterization and Pharmacologic Targeting of EZH2, a Fetal Retinal Protein and Epigenetic Regulator, in Human Retinoblastoma
Retinoblastoma (RB) is the most common primary intraocular cancer in children, a nd the third most common cancer overall in infants. No molecular-targeted therapy for this lethal tumor exists. Since the tumor suppressor RB1, whose genetic inactivation underlies RB, is upstream of the epigenetic regu...
Autores principales: | Khan, Mehnaz, Walters, Laura L., Li, Qiang, Thomas, Dafydd G., Miller, Jason M.L., Zhang, Qitao, Sciallis, Andrew P., Liu, Yu, Dlouhy, Brian J., Fort, Patrice E., Archer, Steven M., Demirci, Hakan, Dou, Yali, Rao, Rajesh C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626270/ https://www.ncbi.nlm.nih.gov/pubmed/26280220 http://dx.doi.org/10.1038/labinvest.2015.104 |
Ejemplares similares
-
The Targetable Epigenetic Tumor Protein EZH2 is Enriched in Intraocular Medulloepithelioma
por: Avedschmidt, Sarah E., et al.
Publicado: (2016) -
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
por: Lin, Zhuangling, et al.
Publicado: (2023) -
Persistent fetal vasculature feeding a retinoblastoma
por: Thirumalesh, M B, et al.
Publicado: (2019) -
Scleral ectasia stabilization following intra-arterial chemotherapy in an eye with recurrent retinoblastoma
por: Pan, Warren, et al.
Publicado: (2023) -
Targeting epigenetics in sarcomas through EZH2 inhibition
por: Italiano, Antoine
Publicado: (2020)